Literature DB >> 9683147

Anterior uveitis associated with latanoprost.

R D Fechtner1, A S Khouri, T J Zimmerman, J Bullock, R Feldman, P Kulkarni, A J Michael, T Realini, R Warwar.   

Abstract

PURPOSE: To report the association of anterior uveitis with the use of latanoprost.
METHODS: We studied four patients with complicated open-angle glaucoma who had anterior uveitis associated with the use of latanoprost. The uveitis was unilateral and occurred only in the eye receiving latanoprost in three patients. In one patient, latanoprost was used in both eyes, and the uveitis was bilateral. Four of five eyes had a history of prior inflammation and/or prior incisional surgery. All patients were rechallenged with the drug.
RESULTS: The uveitis improved after cessation of latanoprost with or without topical corticosteroids. It recurred after rechallenging with latanoprost in all eyes.
CONCLUSION: There is a possible association between latanoprost and anterior uveitis. Topical prostaglandin analogs may be relatively contraindicated in patients with a history of uveitis or prior ocular surgery. This association may also be possible in eyes that have not had previous uveitis or incisional surgery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683147     DOI: 10.1016/s0002-9394(98)00071-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  36 in total

Review 1.  Efficacy and adverse effects of medications used in the treatment of glaucoma.

Authors:  C B Camras; C B Toris; R R Tamesis
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 3.923

Review 2.  Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy.

Authors:  I Goldberg
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

3.  Anterior uveitis is associated with travoprost.

Authors:  Manjula Kumarasamy; Shrivatsa P Desai
Journal:  BMJ       Date:  2004-07-24

4.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  M Reza Razeghinejad
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

Review 5.  Evolving paradigms in the medical treatment of glaucoma.

Authors:  John S Cohen; Anup K Khatana; Linda J Greff
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

6.  Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.

Authors:  Tin Aung; Paul T K Chew; Francis T S Oen; Yiong-Huak Chan; Lennard H Thean; Leonard Yip; Boon-Ang Lim; Jade Soh; Steve K L Seah
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

7.  Efficacy and safety of latanoprost in eyes with uveitic glaucoma.

Authors:  Nikos N Markomichelakis; Agori Kostakou; Ioannis Halkiadakis; Sonia Chalkidou; Dimitrios Papakonstantinou; Gerasimos Georgopoulos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-28       Impact factor: 3.117

8.  Travoprost in the management of open-angle glaucoma and ocular hypertension.

Authors:  Philippe Denis; David Covert; Anthony Realini
Journal:  Clin Ophthalmol       Date:  2007-03

9.  First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprost.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2007-09

10.  Bimatoprost in the treatment of eyelash hypotrichosis.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2010-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.